Insider Spends CN¥134m Buying More Shares In Rici Healthcare Holdings
Insider Spends CN¥134m Buying More Shares In Rici Healthcare Holdings
Rici Healthcare Holdings Limited (HKG:1526) shareholders (or potential shareholders) will be happy to see that the VP & Executive Director, Hong Mei, recently bought a whopping HK$134m worth of stock, at a price of HK$0.50. Aside from being a solid chunk in its own right, the deft move also saw their holding increase by some 31%.
瑞智医疗控股有限公司(HKG: 1526)的股东(或潜在股东)将很高兴看到副总裁兼执行董事洪梅最近以0.50港元的价格购买了价值高达1.34亿港元的股票。这一灵巧的举动不仅本身就占据了相当大的份额,还使他们的持股量增加了约31%。
See our latest analysis for Rici Healthcare Holdings
查看我们对瑞慈医疗控股公司的最新分析
Rici Healthcare Holdings Insider Transactions Over The Last Year
瑞慈医疗控股去年内幕交易
Notably, that recent purchase by Hong Mei is the biggest insider purchase of Rici Healthcare Holdings shares that we've seen in the last year. Even though the purchase was made at a significantly lower price than the recent price (HK$1.12), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
值得注意的是,洪美最近的收购是我们去年对Rici Healthcare Holdings股票的最大一次内幕收购。尽管此次收购的价格明显低于近期价格(1.12港元),但我们仍然认为内幕买入是积极的。由于它是以较低的估值发生的,因此它并不能告诉我们内部人士是否会认为今天的价格具有吸引力。
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
你可以在下面看到过去 12 个月内幕交易(公司和个人)的直观描述。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
内部人士总是会买入很多股票。因此,如果这适合你的风格,你可以逐一查看每只股票,也可以看看这份免费的公司名单。(提示:业内人士一直在购买它们)。
Does Rici Healthcare Holdings Boast High Insider Ownership?
Rici Healthcare Holdings是否拥有很高的内部所有权?
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Rici Healthcare Holdings insiders own about HK$977m worth of shares (which is 55% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
测试公司领导者与其他股东之间一致性的另一种方法是查看他们拥有多少股份。通常,内部人士的所有权越高,内部人士长期建立公司的可能性就越大。瑞慈医疗控股内部人士拥有价值约9.77亿港元的股份(占该公司55%的股份)。我喜欢看到这种程度的内部所有权,因为它增加了管理层考虑股东最大利益的机会。
So What Do The Rici Healthcare Holdings Insider Transactions Indicate?
那么,瑞慈医疗控股公司的内幕交易表明了什么?
It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Rici Healthcare Holdings. Looks promising! I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow for free.
很高兴看到最近的内幕收购。长期的内幕交易也给了我们信心。除了较高的内部所有权外,该分析还表明,内部人士对Rici Healthcare Holdings非常看好。看起来很有希望!我喜欢更深入地了解一家公司过去的表现。您可以免费访问这张过去的收入、收入和现金流的交互式图表。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
如果你想看看另一家公司——一家财务状况可能优越的公司——那么千万不要错过这份免费的股本回报率高、债务低的有趣公司的名单。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,内部人士是那些向相关监管机构报告交易的个人。目前,我们仅对公开市场交易和直接利益的私人处置进行核算,但不考虑衍生品交易或间接权益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。